FDA Adverse Event Injury Summary report: N

ADVANTA VXT

MDR report key: 2963556 · Received January 2, 2013

Report

Report Number
1219977-2012-00154
Event Type
Injury
Date Received
January 2, 2013
Date of Event
February 8, 2011
Report Date
February 14, 2011
Manufacturer
ATRIUM MEDICAL CORP.
Product Code
DSY
PMA / PMN Number
K992960
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE RETURNED DEVICE WAS EVALUATED. ALMOST THE ENTIRE SURFACE OF THE EXPLANTED GRAFT SEGMENTS RECEIVED WAS COVERED WITH A THIN FILM. DAMAGE TO THE BEADING AND TO THE OUTER SURFACE WAS OBVIOUS THAT MAY HAVE BEEN CAUSED BY IMPROPER HANDLING. THE THIN FILM COULD ONLY BE DETECTED USING THE DIGITAL IMAGING MICROSCOPE. THE WALL THICKNESS OF THE EXPLANTED GRAFT SAMPLE FALLS WITHIN GRAFT SPECIFICATION. THIS INDICATES THAT THE GRAFT HAD NO WALL DEFECT. IN ADDITION, THE LOT HISTORY OF THE GRAFT WAS REVIEWED AND THE PRODUCT WAS FOUND TO HAVE MET ALL SPECIFICATIONS. IT IS NOT KNOWN WHEN THE DAMAGE TO THE BEADING AND THE GRAFT SURFACE OCCURRED, BUT THE DAMAGE TO THE GRAFT SURFACE MAY HAVE CREATED A CONDITION FOR SEROMA BUILD UP. LITERATURE REVIEW SUGGESTS THAT SEROMA FORMATION IS NOT UNUSUAL AND HAS MANY CAUSES THAT ARE OFTEN IATROGENIC OR BIOLOGIC IN ORIGIN. NO DEFINITE CAUSES CAN BE DETERMINED.

Description of Event or Problem · 1

ON (B)(6) 2010 THE GRAFT WAS TUNNELED IN THE ANTERIOR CHEST OF A (B)(6) MALE PATIENT AND SUTURED IN END TO SIDE FASHION TO THE LEFT AND RIGHT AXILLARY ARTERIES. HEPARIN WAS ADMINISTERED AND 5-0 PROLINE SUTURE WAS USED. THE PATIENT RECEIVED PROTAMINE POSTOPERATIVELY. ON (B)(6) 2011 A RE-OPERATION WAS PERFORMED DUE TO A SEROMA FORMATION AROUND THE GRAFT. A 100ML OF LIGHT YELLOW TRANSUDATE FLUID WAS COLLECTED. THE ADVANTA VXT GRAFT WAS CUT AND REMOVED AND THE TISSUE ADHESION SURROUNDING THE GRAFT WAS MILD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1597 ADVANTA VXT DSY ATRIUM MEDICAL CORP. 22213 A122507

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention PROLENE| PROTAMINE| SUTURES| HEPARIN